The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TBC AFT Pharmaceuticals Pty Ltd
Product name
TBC
Sponsor
Accepted date
Sep-2023
Active ingredients
pyrazinamide
Proposed indication
For patients with active tuberculosis caused by Mycobacterium tuberculosis.
Application type
A (new medicine)
Publication date
Sep-2023
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.